172 related articles for article (PubMed ID: 34982445)
21. The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritis.
Bresnihan B
Semin Arthritis Rheum; 2001 Apr; 30(5 Suppl 2):17-20. PubMed ID: 11357167
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of inhibiting tumour necrosis factor alpha and interleukin 1 in patients with rheumatoid arthritis: a meta-analysis and adjusted indirect comparisons.
Nixon R; Bansback N; Brennan A
Rheumatology (Oxford); 2007 Jul; 46(7):1140-7. PubMed ID: 17478472
[TBL] [Abstract][Full Text] [Related]
23. Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.
Kunwar S; Dahal K; Sharma S
Rheumatol Int; 2016 Aug; 36(8):1065-75. PubMed ID: 27105880
[TBL] [Abstract][Full Text] [Related]
24. The AMPK modulator metformin as adjunct to methotrexate in patients with rheumatoid arthritis: A proof-of-concept, randomized, double-blind, placebo-controlled trial.
Abdallah MS; Alarfaj SJ; Saif DS; El-Naggar ME; Elsokary MA; Elsawah HK; Abdelsattar Zaki S; Wahsh EA; Abo Mansour HE; Mosalam EM
Int Immunopharmacol; 2021 Jun; 95():107575. PubMed ID: 33773207
[TBL] [Abstract][Full Text] [Related]
25. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
Kalliolias GD; Liossis SN
Expert Opin Investig Drugs; 2008 Mar; 17(3):349-59. PubMed ID: 18321234
[TBL] [Abstract][Full Text] [Related]
26. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial.
Ruscitti P; Masedu F; Alvaro S; Airò P; Battafarano N; Cantarini L; Cantatore FP; Carlino G; D'Abrosca V; Frassi M; Frediani B; Iacono D; Liakouli V; Maggio R; Mulè R; Pantano I; Prevete I; Sinigaglia L; Valenti M; Viapiana O; Cipriani P; Giacomelli R
PLoS Med; 2019 Sep; 16(9):e1002901. PubMed ID: 31513665
[TBL] [Abstract][Full Text] [Related]
27. Leflunomide in monotherapy of rheumatoid arthritis: meta-analysis of randomized trials.
Golicki D; Newada M; Lis J; Pol K; Hermanowski T; Tłustochowicz M
Pol Arch Med Wewn; 2012; 122(1-2):22-32. PubMed ID: 22353705
[TBL] [Abstract][Full Text] [Related]
28. Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a tumour necrosis factor inhibitor: a systematic review and economic evaluation.
Malottki K; Barton P; Tsourapas A; Uthman AO; Liu Z; Routh K; Connock M; Jobanputra P; Moore D; Fry-Smith A; Chen YF
Health Technol Assess; 2011 Mar; 15(14):1-278. PubMed ID: 21439251
[TBL] [Abstract][Full Text] [Related]
29. Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectives.
Bresnihan B
Clin Exp Rheumatol; 2002; 20(5 Suppl 27):S32-4. PubMed ID: 14989427
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis.
Abushouk AI; Ahmed H; Ismail A; Elmaraezy A; Badr AS; Gadelkarim M; Elnenny M
Rheumatol Int; 2017 Jul; 37(7):1053-1064. PubMed ID: 28236221
[TBL] [Abstract][Full Text] [Related]
31. Good response to infliximab in rheumatoid arthritis following failure of interleukin-1 receptor antagonist.
Bao J; Yue T; Li T; He DY; Bao YX
Int J Rheum Dis; 2016 Apr; 19(4):370-6. PubMed ID: 24798350
[TBL] [Abstract][Full Text] [Related]
32. An open-label pilot study of the efficacy and safety of anakinra in patients with psoriatic arthritis refractory to or intolerant of methotrexate (MTX).
Jung N; Hellmann M; Hoheisel R; Lehmann C; Haase I; Perniok A; Hallek M; Rubbert A
Clin Rheumatol; 2010 Oct; 29(10):1169-73. PubMed ID: 20532937
[TBL] [Abstract][Full Text] [Related]
33. A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis.
Turkstra E; Ng SK; Scuffham PA
Curr Med Res Opin; 2011 Oct; 27(10):1885-97. PubMed ID: 21848493
[TBL] [Abstract][Full Text] [Related]
34. Adalimumab: a review of its use in rheumatoid arthritis.
Bang LM; Keating GM
BioDrugs; 2004; 18(2):121-39. PubMed ID: 15046527
[TBL] [Abstract][Full Text] [Related]
35. Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo-controlled trial.
van Vollenhoven RF; Kinnman N; Vincent E; Wax S; Bathon J
Arthritis Rheum; 2011 Jul; 63(7):1782-92. PubMed ID: 21452294
[TBL] [Abstract][Full Text] [Related]
36. [The efficacy and safety of tocilizumab combined with disease-modifying anti-rheumatoid drugs in the treatment of active rheumatoid arthritis: a multi-center, randomized, double-blinded, placebo-controlled trial].
Shi Q; Zhao Y; Bao CD; Li XF; Huang F; Zhu P; Li ZG; Gu JR; Zhang ZY; Zhao DB; Zhao SL; Jiang QD; Tian J; Zhang FC
Zhonghua Nei Ke Za Zhi; 2013 Apr; 52(4):323-9. PubMed ID: 23925361
[TBL] [Abstract][Full Text] [Related]
37. Anakinra: a review of its use in the management of rheumatoid arthritis.
Waugh J; Perry CM
BioDrugs; 2005; 19(3):189-202. PubMed ID: 15984903
[TBL] [Abstract][Full Text] [Related]
38. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
Fleischmann RM; Schechtman J; Bennett R; Handel ML; Burmester GR; Tesser J; Modafferi D; Poulakos J; Sun G
Arthritis Rheum; 2003 Apr; 48(4):927-34. PubMed ID: 12687534
[TBL] [Abstract][Full Text] [Related]
39. [The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis].
Riente L
Reumatismo; 2004; 56(1 Suppl 1):74-9. PubMed ID: 15201943
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of jakinibs in rheumatoid arthritis: a systematic review and meta-analysis.
Yin Y; Liu M; Zhou E; Chang X; He M; Wang M; Wu J
Clin Rheumatol; 2021 Oct; 40(10):3989-4005. PubMed ID: 33990888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
